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Abstract
OBJECTIVE: To investigate the effect of icariin on
proliferation of bone marrow mesenchymal stem
cells (BMSCs) in Sprague-Dawley (SD) rats.
METHODS: BMSCs were obtained from SD rat
bone marrow with differential time adherent meth-
od. Its characteristic was identified through differ-
entiation cell surface antigens and the multi-lin-
eage (osteo/adipo/chondo) differentiation poten-
tial. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) method and 5-Bromo-2-De-
oxyuridine (BrdU) incorporation were applied to de-
tect the effect of icariin on BMSCs proliferation.
Flow cytometry was used to detect proliferation in-
dex of BMSCs. The mRNA level and the distribution
of β-catenin were evaluated by Real-time Poly-
merase Chain Reaction (PCR) and Immunofluores-
cent staining respectively. Western blot was used
to detect protein expression levels of β-catenin, gly-
cogen synthase kinase-3 beta (GSK-3β), phos-
pho-glycogen synthase kinase-3 beta (pGSK-3β)
and cyclinD1.
RESULTS: Icariin promoted BMSCs proliferation at
the concentration of 0.05-2.0 mg/L. The percentage
of BrdU positive cells of BMSCs was increased from
40.98% to 70.42%, and the proliferation index val-
ue was increased from 8.9% to 17.5% with the treat-
ment of 0.05 mg/L icariin, which significance values
were both less than 0.05. Compared with the con-
trol group, total and nuclear β-catenin proteins, as
well as β-catenin mRNA expression, were all in-
creased with icariin treatment. Meanwhile, the
phosphorylation level of GSK-3β and cyclinD1 pro-
tein expressions were also increased in BMSCs with
icariin treatment.
CONCLUSION: The findings of the present study
demonstrated that low dosage of icariin could pro-
mote BMSCs proliferation. The activation of Wnt/
β-catenin pathways was involved in this process.
© 2016 JTCM. All rights reserved.
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INTRODUCTION
Bone marrow mesenchymal stem cells (BMSCs) are
characterized by their self-renewal and multi-lineage
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differentiation potential, which can differentiate into
osteoblasts,1 chondrocytes,2,3 adipocytes,4 endothelial
cells and neuronal-like cells.5 As the precursor cells of
osteoblast, BMSCs not only regulate normal skeletal
homeostasis, but also play an important role in fracture
repair.6 Although the role of BMSCs in the mainte-
nance and repair of bone has been recognized, the in-
fluential factors and underlying mechanism has not
been elucidated well yet.
The wingless-related mouse mammary tumor virus
(MMTV) integration site (Wnt) family contains cyste-
ine-rich secretory glycoproteins. Wnt proteins are in-
volved in a variety of cellular processes including the
growth, differentiation and survival of cells, through
modulating target gene transcription by the canonical
or non-canonical Wnt pathway. The canonical Wnt
pathway is also known as the Wnt/β-catenin signal-
ing pathway, which mainly activates the expression of
target genes in the nucleus. In the absence of Wnt
signaling, the destruction complex, which contains
scaffolding protein, Axin and adenomatous polyposis
coli protein (APC), mediates phosphorylation of be-
ta-catenin by sequential recruitment of glycogen syn-
thetase (GSK3Beta) and casein kinase 1 (CK). Phos-
phorylated β-catenin is recognized by the Skp1/Cul1/
F-box (SCF) complex and ubiquitinated for degrada-
tion by the proteasome. Thus, cytoplasm β-catenin
protein levels are kept low in the absence of Wnt sig-
naling. When Wnt proteins such as Wnt3a bind to
their receptor, low-density lipoprotein receptor-relat-
ed protein 5/6 (LRP5/6) and Frizzled, a series of
downstream cascade reactions are activated. The Di-
sheveled protein (a compound of Wnt signaling path-
way) and GBP [the glycogen synthase kinase-3 beta
(GSK-3β) inhibition protein] are activated; the degra-
dation of β-catenin is inhibited and the accumulation
of intracellular β-catenin is increased by the phosphor-
ylation of GSK-3β. Stabilized β-cateninthen translo-
cate into nucleus to activate RNA transcription of
downstream target genes by binding to lymphoid en-
hancer factor-1 (LEF1)/T-cell factor (TCF) and re-
cruiting coactivators.7,8 Additionally, some Wnt pro-
teins such as Wnt5a and Wnt11 exert their biological
functions by non-canonical Wnt signaling pathway,
which would not induce the accumulation of β-
catenin.9,10 There have been a lot of studies indicating
that MSCs expressed a number of Wnt ligands
(Wnt2, Wnt 4, Wnt5a, Wnt11 and Wnt16) and Wnt
receptors,11 extensive researches also demonstrated that
the activation of Wnt signaling result in a high bone
mass phenotype in the human and murine, in which
bone biopsies show increased bone volume and de-
creased fat within the marrow, and β-catenin is re-
quired for postnatal bone maintenance.12-14 However,
in vitro studies of the role of Wnt signaling in the os-
teoblast-differentiation of MSCs is inconclusive. On
the one hand, studies showed that Wnt signaling pro-
moted osteoblastogenesis of MSCs by increasing the
transactivation ability of Runx2;15,16 on the other
hand, some researches indicated that Wnt signaling
has an inhibitory effect on osteogenic and adipogenic
differentiation in human MSCs, high levels ofβ-catenin signaling reduced osteogenic differentiation
of stem cells.17,18 Meanwhile, activation of Wnt signal-
ing is found to be involved in the self-renewal and
proliferation processes of some types of stem cells,
such as haemopoietic stem cells,19 neural stem cells20
and BMSCs,21,22 these effects are related to the up-reg-
ulation of cylcinD1 and decreases of cell apoptosis.23
Suppression of β-catenin/TCF signaling leads to a de-
cline of cyclin D1 and arrests BMSCs to re-enter into
cell cycle.However, the overexpression of LRP5 can in-
crease BMSC proliferation significantly.12,24 All these
results showed that Wnt signaling played a vital role
in MSCs proliferation.
Icariin (the structure is shown in Figure 1) is a flavo-
noid isolated from Epimedium pubescens, which is a
Chinese herb that is found to promote bone density
and lumbar bone mineral density by increasing the
mineral content.25,26 As the active compound of pubes-
cens, icariin was reported to have a definite antiosteo-
porotic effect on estrogen deficiency-induced bone
fracture.27 It also exert potent osteogenic effects
through inducing expression of runt-related transcrip-
tion factor 2 (Runx2) and activating bone morphoge-
netic protein (BMP) signaling in pre-osteoblastic
mouse obsteoblastic MC3T3-E1 cells and mouse pri-
mary osteoblasts.28-30 Our research group carried out a
series of studies on Chinese herbs that are beneficial
to bone metabolism. We found that the formula con-
taining Epimedium pubescens and the single icariin
promoted the proliferation of osteoblast and induced
their differentiation by increasing the activity of alka-
line phosphatase (ALP), collagen I and osteocalcin.
These findings indicated that Icarrin might regulate
the proliferation and osteogenic differentiation activity
of BMSCs. However, the underlying mechanism re-
mains unclear. In this study, the effect of icariin on
rat BMSCs proliferation was investigated and its po-
tential mechanism was addressed.
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Figure 1 Chemical structure of icariin
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MATERIALS ANDMETHODS
Main reagents
Icariin was purchased from National Institute for the
Control of Pharmaceutical and Biological Products
(Beijing, China). It was identified with HPLC at puri-
ty higher than 98%and dissolved in dimethyl sulfoxide
(DMSO, Sigma, St. Louis, MO, USA). β-catenin
mouse monoclonal antibody was purchased from BD
Transduction Laboratories (BD Biosciences, NJ, USA).
Glyceraldehyde-3-phosphate dehydrogenase (GAP-
DH) rabbit monoclonal antibody, pGSK-3β (Ser9)
rabbit polyclonal antibody, GSK-3β rabbit polyclonal
antibody, cyclinD1 rabbit polyclonal antibody and
Phototope-HRP Western Blot Detection System con-
taining anti-rabbit IgG, HRP-linked antibody were
purchased from Cell Signaling Technology, Inc. (Dan-
vers, MA, USA). 5-Bromo-2'-Deoxyuridine (BrdU)
was purchased from Sigma-Aldrich and rat BrdU anti-
body was purchased from AbD Serotec (MorphoSys,
Germany).
Cell culture
Female adult Sprague-Dawley rats of cleaning grade,
three-month-old, weighing (200 ± 20) g were obtained
from the Laboratorial Animal Center of Nanjing Medi-
cal University (Certificate of quality No. SCXK[Shu]
2008-0004-0004482). The primary BMSCs were iso-
lated and purified according to the method described
by Wakitani et al 31with modifications. Cells were incu-
bated at 37 ℃ in a humidified atmosphere with 5%
CO2 in low-glucose Dulbecco's modified Eagle's medi-
um (DMEM-LG; Gibco, CA, USA) containing 10%
fetal bovine serum (FBS; TBD, Tianjin, China) and
1% penicillin/streptomycin. Half liquid volume was re-
newed after 24 h and then the culture medium was re-
placed every three days. The third, fourth and fifth pas-
sage cells were applied for this study.
Flow cytometer technology
Flow cytometric analysis of specific surface antigens
was used to identify the BMSCs characteristics. Cells
were incubated with monoclonal antibodies for 30
min, including anti-CD29, anti-CD44, anti-CD34
and anti-CD45 (Chemicon, MA, USA). Then the cells
were fixed with 1% paraformaldehyde. Non-specific
fluorescence was determined using equal aliquots of
the cell preparation that were incubated with an-
ti-mouse monoclonal antibodies. Data were acquired
and analyzed on the fluorescence-activated cell sorter
(FACS Vantage SE, Becton Dickinson) using 525 nm
and 575 nm band pass filters for green FITC fluores-
cence and red PE fluorescence respectively.
To calculate the proliferation index, the cells were fixed
with 70% prechilled ethanol for 24 h. After being di-
luted to 1 × 106 cells /ml with PBS containing 1 g/L
RnaseA, the cells were placed into a water bath at
37 ℃ for 30 min, then incubated with 50 mg/L prop-
idium iodide solution in dark at 4℃ for another 30 min.
Data were acquired and analyzed on FACS. Prolifera-
tion index = (S + G2/M)/ (G0/G1+ S + G2/M) × 100%.
MTT assay
BMSCs were seeded in 96-well plate and treated with
10% FBS DMEM-LG medium plus with 0.1%
DMSO or icariin at various concentrations (0.05, 0.1,
0.2, 0.5, 1, 2, 5, 10, 20, 50 and 100 mg/L) after cell
cycle synchronization. The cells were incubated for 1,
3, 5, 7, 9 or 11 days respectively. Four hours before
the end of incubation, cells were washed twice with
PBS and incubated with 0.5g/L MTT, the formazan
salts were dissolved in 200 μL DMSO. The absor-
bance (A) values were obtained at 570 nm using an
enzyme-linked immunosorbent assay reader (Bio-Rad,
Hercules, CA,USA).
BrdU incorporation assay & Immunofluorescence
staining
Cells were seeded in 24-well plates which pre-placed
poly-L-lysine coated cover glassand treated with 10%
FBS DMEM-LG mediumpluswith 0.1% DMSO or
0.05 mg/L icariin. Five days later, cells were labelled
with 10μM BrdU for 48 h and then fixed in 4% PFA.
For BrdU and β-catenin immunofluorescence staining,
the fixed cells were treated with 2NHCl at 37℃ for 1 h,
and then incubated with 0.1 M borate buffer for 10 min.
After blocking, the cells were incubated with BrdU an-
tibody (1∶ 400) or β-catenin antibody (1∶500) at
4 ℃ overnight, then incubated with secondary anti-
body (Alexa 488 Goat anti rat 1∶400, or Alexa 568
Goat anti mouse 1∶400) at room temperature for 2 h.
The cell nuclei were stained by 4,6-diamino-2-phenyl
indole (DAPI, 0.1 μg/L, sigma, St. Louis, MO, USA).
Finally, cells were mounted in anti-fade mounting solu-
tion (Dako, Hamburg, Germany). Images were ac-
quired using a fluorescent microscope (Nikon, Japan).
At least 10 random images of each staining condition
were captured at × 200 magnification.
Real-time polymerase chain reaction (PCR) analysis
Cells were incubated with 10% FBS DMEM-LG with
supplement of icariin (0.05 mg/L) or not. Total RNA
was extracted using Trizol reagent (Invitrogen, CA,
USA) after incubation for 7 days. cDNA was synthe-
sized using Perfect Real Time ExScriptTM RT Reagent
Kit (TaKaRa, Japan) according to the manufacturer's
instructions. PCR was performed using a Chromo 4™
Real-Time Detector (MJ research, Watertown, MA,
USA) and Perfect Real Time SYBR Premix Ex TaqTM
(TaKaRa, Japan). The primers were synthesized from
Shanghai Sangon Biological Engineering Technology
and Services Co., Ltd. (Shanghai, China). The primers'
sequence and annealing temperature are shown in Ta-
ble 1. All reactions were carried out in triplicate and
the relative β-catenin mRNA expressions were ob-
tained by comparing with GAPDH mRNA expression
of the same sample.
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Western blot analysis
Cells were cultured as the above mentioned method.
Total proteins were extracted using Trizol reagent ac-
cording to the manufacturer's instructions. In short, af-
ter aspirating the aqueous phase for RNA extraction,
dehydrated alcohol was added to precipitate DNA.
The supernatant was collected and isopropyl alcohol
was added to precipitate the proteins. After being
washed with 95% ethanol containing 0.3 mol/L guani-
dine hydrochloride and dehydrates alcohol, the pro-
teins were resolved in the 1% sodium dodecyl sulfate
(SDS) solution and stored at－80 ℃. Nuclear proteins
were extracted using NE-PER Nuclear Protein Extrac-
tion Kit (Pierce, IL, USA) according to the manufactur-
er's instructions. For Western blot, denatured protein
samples were resolved on SDS-polyacrylamide gels and
transferred to PVDF membranes (Millipore, MA,
USA). After blocking, membranes were incubated over-
night at 4 ℃ with β-catenin (1∶1000), pGSK-3β
(Ser9) (1∶1000), GSK-3β (1∶1000), cyclinD1 (1∶
1000) and GAPDH (1∶3000) respectively, followed by
incubation with secondary antibodies (1∶2000) respec-
tively. Chemiluminescence detection was performed us-
ing ECL advance Western blotting detection reagents
(BD biosciences, NJ, USA).
Statistical analysis
All Data were presented as mean ± standard deviation
( xˉ ± s). Statistics analysis was performed using SPSS
18.0 (IBM, Somers, NY, USA); were analysis of vari-
ance was conducted for multiple group comparison
and 2-tailed Student's t test was performed for
two-group comparison. P < 0.05 was considered statis-
tically significant.
RESULTS
Characters of BMSCs
To identify the characteristic of BMSCs, we first detect-
ed the surface antigens of BMSCs at the third passage
by flow cytometry. We found that the positive expres-
sion ratios of CD29, CD44, CD34 and CD45 were
98.7, 89.5, 0.66 and 0.97% respectively, indicating
that the cells we harvested were positive for CD29 and
CD44, which were the markers of integrin and adhe-
sion molecule. Meanwhile, they were negative for
CD34 and CD45, which were the markers of early he-
matopoietic stem cells and hematopoietic cells. Further-
more, we tested these cells' multi-lineage differentia-
tion potency. The results showed that with the pres-
ence of osteogenic stimulus, most of the cultured cells
showed alkaline phosphatase-positive black or grey ag-
gregates at day 14 (Figure 2A), as well as alizarin red
stain-positive nodules (Figure 2B) at day 21. After incu-
bation in adipogenic medium, accumulation of lip-
id-rich vacuoles appeared and these cells showed Oil
red-O-positive staining in the cytoplasm with an eccen-
tric deviation of the nucleus (Figure 2C). Additionally,
cells treated with chondrogenic induction medium
showed positive toludine blue staining in aggrecan-rich
extracellular matrix at day 21 (Figure 2D). All these re-
sults indicated that the isolated cells exhibited the prop-
erties of MSCs.32
Effects of icariin on BMSC proliferation
To determine the effect of icariin on the proliferation
of BMSCs, the cells were treated with various concen-
trations of icariin. MTT results showed that cells in all
the groups entered into exponential growth phase at
day 3 after the addition of icariin. The absorbance val-
ues of cells that were treated with 0.05 to 10 mg/L icar-
iin, reached a peak from day 7 to day 9, and subse-
quently entered into a platform phase. However, in the
higher concentration group, cell proliferation reached a
peak from day 5 to day 7 and then stated to decrease
gradually (Figure 3). Statistical analysis showed that,
compared with the control group (0 mg/L), the prolif-
Figure 2 Characteristic of BMSCs
A and B: Osteogenic-lineage induction results of BMSCs. BM-
SCs were cultured for 14 days and 21 days, alkaline phospha-
tase-positive black or grey aggregates (A, × 10) and calcium
nodules (B, × 10) were visualized by alkaline phosphatase
staining and Alizarin red staining respectively. C: adipogen-
ic-lineage induction result of BMSCs. Lipid-rich vacuoles
were visualized by Oil red-O staining (× 10). D: Chondrogen-
ic-lineage induction result of BMSCs. aggrecan-rich extracel-
lular matrix was evident by toludine blue staining at day 21
(× 20). BMSCs: bone marrowmesenchymal stem cells.
A B
C D
Gene
β-catenin
GAPDH
Sequence
F: 5'- AACGGCTTTCGGTTGAGCTG -3'
R: 5' -TGGCGATATCCAAGGGCTTC -3'
F: 5'- GGCACAGTCAAGGCTGAGAATG -3'
R: 5'- ATGGTGGTGAAGACGCCAGTA -3
Tm (℃)
64.85
64.47
64.42
62.81
Table 1 Primer sequences and melt temperature (Tm) values
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erations of BMSCs treated with icarrin in concentra-
tion of 0.05-2 mg/L increased significantly and the val-
ue of the 0.05 mg/L icarrin group was the highest. But
when the concentration was higher than 5 mg/L, there
was no difference between the icarrin group and the con-
trol group. Based on these results, we chose 0.05 mg/L
as the experimental dosage in the following study.
Icariin promote BMSCs to enter into cell cycle
BrdU incorporation assay results showed that the per-
centage of Brdu-positive cells was increased from
40.98% to 70.42% (Figure 4A, 4B) after icariin treat-
ment. The Flow cytometer results also showed that
there was only about 8.90% ± 0.46% cells entering in-
to the S and G2/M phases in the control group. How-
ever, after treated with 0.05 mg/L icariin, the ratio in-
creased significantly to 17.50% ± 2.14% (Figure 4C,
4E). Furthermore, cell cycle protein cyclinD1, which
could drive cell cycle progression to promote cell
growth, was also increased significantly (Figure 4D,
4F).
Icariin induced the activation of Wnt / β-catenin
signal during BMSCs proliferation
Real time PCR analysis showed that β-catenin
mRNA expression was obviously up-regulated with
the treatment of icariin (Figure 5A). Immunofluores-
cence staining results displayed that the fluorescence
intensity of the icariin group was higher than that of
the control group, and there are more overlap of β-
catenin and nuclear in the icariin group (Figure 5B).
Western blot results also indicated that icariin not on-
ly significantly up-regulated the total β- catenin ex-
pression but also increased the accumulation ofβ-catenin in the nuclear (Figure 5C, 5D). Mean-
while, the activity of its repressor factor, GSK-3β,
was obviously decreased accompanying with the in-
crease of pGSK-3β (Figure 6).
DISCUSSION
BMSCs proliferation is mainly controlled by two mech-
anisms. The first is asymmetric division, by which two
types of cells are produced. One is the identical daugh-
ter stem cell and the other is a second progenitor cell
which becomes committed to a lineage-specific differ-
entiation program. In the second mechanism, BMSCs
are split into two identical sister chromatids. The inter-
actions of the external stimulus and the internal regula-
tion of transcription factor have influence on the prolif-
eration type of BMSCs.33 It is found that there are only
about 0.001%-0.01% BMSCs in marrow aspirates.
Most of them were in a quiescent period and did not
go into cell cycle, which restricted the application of
BMSCs as a potential regenerative tissue resource.32 So
it is necessary to amplify large amounts of BMSCs in
vitro. Icariin, as a single compound extract of Epimedi-
um pubescens, was reported to exert beneficial effects
in preventing postmenopausal bone loss by its estro-
gen-like activity and strong proliferative and osteogenic
activity of osteoblasts in dose-dependent in vitro.34,35
However, whether icarrin could affect BMSCs biologi-
cal process or not remained unknown.
In this study, the results showed that icariin did not
have obvious cytotoxicity on BMSCs even in high con-
centration (100 mg/L). Icariin (0.05-2.0 mg/L) pro-
duced marked promotional effects on cell proliferation
viability and the cells in the 0.05 mg/L Icarrin group
showed higher cell viability in comparison with other
groups. Furthremore, the Brdu incorporation results in-
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Figure 3 Effect of icariin on BMSC proliferation
Cells were treated with 10% FBS DMEM-LG medium in supplement with or not with various concentrations of Icariin (0.05, 0.1,
0.2, 0.5, 1, 2, 5, 10, 20, 50 and 100 mg/L), cell proliferation viability were detected by MTT method at the time points of days 1, 3,
5, 7, 9 and 11. Data were presented as mean ± standard deviation, aP＜0.01 vs the control group, n = 10. BMSC: bone marrow
mesenchymal stem cell; FBS: fetal bovine serum; DMEM-LG: low-glucose Dulbecco's modified Eagle's medium; MTT: 3-(4,5-Di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
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dicated that more than 75% cells entered into prolifera-
tion process with 0.05 mg/L icariin treatment, it con-
firmed the proliferation promotion effect of icariin on
the BMSCs
Once BMSCs enter into the proliferation state, G1 and
G2 phases are significantly shortened, and DNA con-
tent is changed following the different cell phase of cell
cycle. Similarly, the change of DNA content under cer-
tain stimulating factors will lead to the change of cell
cycle, which influences the cell proliferation subse-
quently.36 The proliferation index, referring to the ratio
of DNA content in S, G2 / M and that of S, G2 /M and
G0 /G1 phases, is an important parameter that reflects
the activity of cell proliferation. To explore the mecha-
nism of icariin on the BMSCs proliferation, cell cycle
analysis was applied here. We found that the DNA con-
tent in S and G2/M phases increased significantly and
the proliferation index was increased to 17.5% in the
presence of icariin, while the control group was only
8.90%, which was coincident with previously reported
results.37 In addition, cylclinD1, a mitogenic signal sen-
sor that forced cells into proliferative cycle from the
G0 phase, was also increased significantly. These results
suggested that icariin can stimulate BMSCs to enter in-
to cell proliferation cycle, so as to achieve the promot-
ing effect of cell proliferation.
Recently, many researchers have found that the Wnt
signaling plays an important role in the proliferation
and survival of BMSCs.38 Bore et al 39 reported that lith-
ium and Wnt3a, could stimulate hMSC proliferation
while retaining the osteogenic or chrondrogenic differ-
entiation pluripotency by providing a mitogenic stimu-
lus to over-activate the Wnt signaling pathway. Mean-
while, Wnt3a also could inhibit the apoptosis of MSCs
and the cell number was found to be increased accord-
ingly, particularly during the expansion period of undif-
ferentiated MSCs. The inhibition of cell apoptosis in-
duced by activation of Wnt signaling pathway was asso-
ciated with the accumulation of cytoplasm β-catenin
and inhibition of GSK-3β activity.40,41 In addition, se-
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Figure 4 Icariin promote BMSCs to enter into cell cycle
A: BrdU incorporation assay result. Cells were treated with 10% FBS DMEM-LG with 0.05 mg/L icariin (A3, A4) or not (A1, A2) for 7
days and labelled with 10 μM BrdU before immunofluorescence staining (Green, ×20), cell nuclei were stained with 4,6-diami-
no-2-phenyl indole (DAPI, blue, ×20); B: quantification of BrdU-positive cell percentage; C: representative flow-cytometry result
image of the control group (C1) and the icariin group (C2); D: CyclinD1 protein expression of the control group (1, 2, 3) and the
icariin group (4,5,6). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was measured as a loading control. E. quantification
results of proliferation index of each group. DNA was stained by propidium iodide (PI) for flow cytometry assay. aP＜ 0.01 vs Ctr,
n = 6. F: quantification results of CyclinD1 protein expression level of each group. Data were presented as mean ± standard devia-
tion. aP＜ 0.01 vs Ctr, n = 6. Ctr: control group; Icariin: the icariin group. BrdU: 5-Bromo-2-D.
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rum withdrawal induced apoptosis of bipotential
C2C12 cells, preosteoblastic cell line MC3T3-E1
and bone marrow-derived OB-6 osteoblasts could be
prevented by the canonical Wnts Wnt3a, Wnt1 and
the non-canonical Wnt5a, accompanied by the in-
creased cell proliferation, commitment, differentiation
and survival.42 All of these findings confirmed that
Wnt signaling was involved in the proliferation of
MSCs. Furthermore, cylclinD1, as one important tar-
get gene of the Wnt/β-catenin signal pathways, was
increased after icariin treatment in this study. So we
hypothesized that there was a certain relationship be-
tween the proliferation-promoting effect of icariin on
BMSCs and Wnt signaling. The amount of β-
catenin, especially the nuclear β-catenin, representing
the activity of the Wnt/β-catenin signaling pathway,
is normally kept at a low level due to the continuous
ubiquitin-proteasome system mediated degradation.
GSK-3β served as a repressor by mediating the degra-
dation of β- catenin. It acts as a downstream regula-
tory switch for numerous signal pathways, such as
the Wnt/β-catenin, Notch, Hedgehog and insulin sig-
naling pathways,43 and is active in unstimulated and
resting cells. Its activity will be diminished in cellular
responses, and the activity of GSK-3β is inhibited by
the phosphorylation of Ser9 that could be induced
by numerous stimuli, such as insulin, 44 Wnt signals,6,40
growth factors and so on.45 Studies demonstrated that
low levels of Wnt signaling were contributed to the
proliferation of uncommitted hMSCs and osteopro-
genitor proliferation, but high levels of Wnt result in
the initiation of osteogenesis, bone tissue engineering
could benefit from the activation of critical levels of
Wnt signaling at defined stages of differentiation.46
In this study, the low dosage icariin (0.05 mg/L) not
only increased β-catenin mRNA expression, but also
promoted the total and nuclear β-catenin protein ac-
cumulation. Meanwhile, the GSK-3β activity was in-
hibited by the increasing of its phosphorylation at
ser9.
In conclusion, we believed that icariin could promote
BMSCs proliferation by forcing cells to enter into cell
cycle at a low dosage, and this effect might be related
to the activation of Wnt/β-catenin signaling.
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Figure 5 Icariin promoted β-catenin mRNA and protein expression level
BMSCs were incubated in 10% FBS DMEM-low glucose medium with 0.05 mg/L icariin
or not for 7 days. A: representative immunofluorescence staining image of the control
group (A1, A2) and the icariin group (A3, A4); B: β-catenin mRNA expression level result
in each group. Data were shown as means ± SD, aP＜ 0.05 vs Ctr, n = 6. Cells were la-
belled with β-catenin antibody (Red, ×20), and DAPI (blue, ×20). C: Total and nuclear
β-catenin protein expression results of the control group (1, 2, 3) and the icariin group
(4, 5, 6). GAPDH was measured as a loading control. D: quantification results of total and
nuclear β-catenin protein expression. Data were shown as mean ± standard deviation.
aP＜ 0.05 vs Ctr, n = 6. Ctr: control group.
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Figure 6 Icariin inhibited GSK-3β activity
BMSCs were incubated in 10%FBS DMEM-LG medium with
0.05mg/L icariin or not for 7 days. A: GSK-3β and pGSK-3β
protein expression results of the control group (1, 2, 3) and
the icariin group (4, 5, 6). B: quantification results of the rela-
tive expression level of pGSK-3β. GSK-3β was measured as
internal reference. GSK-3β: Glycogen synthase kinase-3 be-
ta; pGSK-3β: phosphor-glycogen synthase kinase-3 beta. Da-
ta were shown as mean ± standard deviation. aP＜ 0.01 vs
Ctr, n = 6. Ctr: control group.
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